Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Walter Hargrove

Thoracic Surgery (Cardiothoracic Vascular Surgery) Doylestown, PA Medical Doctor

NPI 1437180122 CMS profile 155232

599 W State St Ste 207, Doylestown, PA 18901

Open in the dashboard

General payments

$48,513

144 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Walter Hargrove of Doylestown, PA is reported in the CMS Open Payments database as having received $48,513 across 144 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,883 20
2024 General $1,647 16
2023 General $838 9
2022 General $21,918 43
2021 General $19,668 23
2020 General $1,223 14
2019 General $1,336 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Walter Hargrove
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Walter Hargrove were reported at $1,883. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Walter Hargrove Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $1,336 $886 $178–$3,167 $163
2020 $1,223 $341 $108–$1,605 $114
2021 $19,668 $453 $125–$1,886 $132
2022 $21,918 $695 $180–$2,566 $149
2023 $838 $745 $205–$2,662 $160
2024 $1,647 $799 $214–$2,967 $164
2025 $1,883 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Atricure, Inc. $44,231 89 payments
  2. Abbott Laboratories $2,389 26 payments
  3. Medtronic Vascular, Inc. $429 6 payments
  4. Abiomed $376 4 payments
  5. Edwards Lifesciences Corporation $330 4 payments
  6. Medtronic, Inc. $238 3 payments
  7. CryoLife, Inc. $167 2 payments
  8. Maquet Cardiovascular U.S. Sales, L.L.C. $108 2 payments
  9. LivaNova USA, Inc. $102 1 payment
  10. Teleflex LLC $67 2 payments
  11. Other $76 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $36,250 16 payments
  2. Food and Beverage $9,515 114 payments
  3. Travel and Lodging $2,749 14 payments
Products named General payments · program years 2019–2025
  1. SYNERGY ABLATION SYSTEM $29,011 42 payments
  2. ATRICLIP LAA EXCLUSION SYSTEM $12,364 24 payments
  3. AtriCure cryoICE cryoSPHERE Cryoablation System $11,253 8 payments
  4. ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) $1,059 10 payments
  5. EPIC $1,042 11 payments
  6. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $1,038 8 payments
  7. Epic Stented Tissue Valve $625 8 payments
  8. ATRICURE ATRICLIP LAA EXCLUSION $558 7 payments
  9. Trifecta GT Tissue Heart Valve $284 2 payments
  10. COREVALVE EVOLUT R $238 3 payments
  11. Other $2,243 31 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$41,699

Medicare's payments for the services billed

Medicare patients

26

Average age 74

Services billed

74

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 50%
Arthritis 50%
Atrial fibrillation 46%
Diabetes 42%
Osteoporosis 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

144 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record